Literature DB >> 1275017

Incidence of infections associated with the intrauterine contraceptive device in an isolated community.

P B Mead, J B Beecham, J V Maeck.   

Abstract

In an attempt to estimate more precisely the frequency of infections associated with the intrauterine contraceptive device (IUD), all gynecologic morbidity resulting from infection and occurring during a two-year period in an isolated community was reviewed. Ten septic abortions occurred, and all but one were associated with IUD use. In 26 gynecologic inpatients (41 per cent of all admissions for acute pelvic inflammatory disease), pelvic infection was associated with IUD use. In contradistinction to the septic abortion data, implicating only the Dalkon Shield, the gynecologic infections were associated with various types of devices.

Entities:  

Keywords:  Abortion, Induced; Abortion, Septic; Contraception; Contraception Failure; Contraceptive Methods--complications; Diseases; Epidemiologic Methods; Family Planning; Incidence; Infections; Iud, Unmedicated--complications; Iud--complications; Measurement; Pelvic Infections; Pregnancy Complications; Research Methodology; Retrospective Studies; Sexually Transmitted Diseases; Studies

Mesh:

Year:  1976        PMID: 1275017     DOI: 10.1016/0002-9378(76)90896-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  The intrauterine contraceptive device.

Authors:  B N Barwin; S Tuttle; E E Jolly
Journal:  Can Med Assoc J       Date:  1978-01-07       Impact factor: 8.262

2.  A study of tubo-ovarian abscess at Howard University Hospital (1965 through 1975).

Authors:  J F Clark; S Moore-Hines
Journal:  J Natl Med Assoc       Date:  1979-11       Impact factor: 1.798

3.  Pelvic peritonitis during biologic therapy for rheumatoid arthritis: a case report and review of the literature.

Authors:  Tsuyoshi Sasaki; Koichi Okamura; Yukio Yonemoto; Chisa Okura; Kenji Takagishi
Journal:  Springerplus       Date:  2014-09-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.